She holds an MA of Arts from Birkbeck, University of London. Languages: English and Arabic. Remote work has transformed the modern workplace by offering flexibility and reducing commute times for ...

The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect cases of hidden, transient arrhythmias that may only last minutes at a time.

Philips is recalling its remote cardiac monitoring software, which has been associated with 109 reported injuries and two reported deaths, according to the Food and Drug Administration.

SAN FRANCISCO, Jan 13 (Reuters) - Philips (PHG.AS), opens new tab CEO Roy Jakobs said he still expects subdued demand in China this year due to healthcare anti-corruption efforts by the Chinese ...

The FDA announced today that a Philips (NYSE: PHG) + recall involving remote cardiac monitoring software is Class I, its most serious recall designation. On Dec. 18, 2024, Philips and its ...